Qilu Pharmaceutical to present 4 posters at the Annual Meeting of the American Society of Clinical Oncology (ASCO)
Caring through Science & Technology Through these results, Qilu has demonstrated its capabilities of Global Drug Discovery and Clinical Development in Oncology. We strive to offer more treatments for patients with unmet medical needs.” — Dr. Oliver Kong M.D., Chief Medical Officer of Qilu Pharmaceutical CHICAGO, ILLINOIS, UNITED STATES, June 1, 2022 /EINPresswire.com/ — Qilu […]